{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:46:46Z","timestamp":1790812006849,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.xphs.2023.07.018","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T21:00:13Z","timestamp":1689973213000},"page":"2552-2560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model"],"prefix":"10.1016","volume":"112","author":[{"given":"Sanaalarab Al","family":"Enazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Kirschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-9551","authenticated-orcid":false,"given":"Kathleen","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9550-9704","authenticated-orcid":false,"given":"Jamal","family":"Saada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7375-7109","authenticated-orcid":false,"given":"Andres F.","family":"Oberhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Bujalowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Motamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salama A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Rytting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-132X","authenticated-orcid":false,"given":"Mostafa A.","family":"Borahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.07.018_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-030-16699-1_9","article-title":"Uterine fibroids","author":"Hurst","year":"2019","journal-title":"Ultrasound Imaging Reprod Med"},{"key":"10.1016\/j.xphs.2023.07.018_bib0002","doi-asserted-by":"crossref","unstructured":"S.E. Bulun, \u201cUterine fibroids,\u201d https:\/\/doi.org\/10.1056\/NEJMra1209993, vol. 369, no. 14, pp. 1344\u20131355, Oct. 2013, https:\/\/doi.org\/10.1056\/NEJMra1209993.","DOI":"10.1056\/NEJMra1209993"},{"issue":"6","key":"10.1016\/j.xphs.2023.07.018_bib0003","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s13346-017-0423-2","article-title":"Drug delivery for the treatment of endometriosis and uterine fibroids","volume":"7","author":"Friend","year":"2017","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fertnstert.2010.08.049","article-title":"Proceedings from the National Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop","volume":"95","author":"Catherino","year":"2011","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0006","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2119\/molmed.2014.00053","article-title":"Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy","volume":"21","author":"Borahay","year":"2015","journal-title":"Mol Med"},{"issue":"9","key":"10.1016\/j.xphs.2023.07.018_bib0007","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1177\/1933719116678686","article-title":"Estrogen receptors and signaling in fibroids: role in pathobiology and therapeutic implications","volume":"24","author":"Borahay","year":"2017","journal-title":"Reprod Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.07.018_bib0008","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2014.07.1238","article-title":"Fibroid growth and medical options for treatment","volume":"102","author":"Chabbert-Buffet","year":"2014","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.xphs.2023.07.018_bib0009","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/s-0037-1606303","article-title":"New and emerging therapies for uterine fibroids","volume":"35","author":"Fritton","year":"2017","journal-title":"Semin Reprod Med"},{"issue":"2","key":"10.1016\/j.xphs.2023.07.018_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4155\/tde.12.144","article-title":"Nanomedicine for uterine leiomyoma therapy","volume":"4","author":"Ali","year":"2013","journal-title":"Ther Deliv"},{"issue":"10","key":"10.1016\/j.xphs.2023.07.018_bib0011","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.steroids.2010.02.016","article-title":"2-Methoxyestradiol\u2013biology and mechanism of action","volume":"75","author":"Mueck","year":"2010","journal-title":"Steroids"},{"issue":"11","key":"10.1016\/j.xphs.2023.07.018_bib0012","first-page":"2084","article-title":"Underlying mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in SKOV3 human ovarian cancer cells","volume":"19","author":"Ding","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0013","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2012.04.002","article-title":"2-Methoxyestradiol causes functional repression of transforming growth factor \u03b23 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells","volume":"98","author":"Salama","year":"2012","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.xphs.2023.07.018_bib0014","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cbf.1557","article-title":"In vitro effects of 2-methoxyestradiol on cell numbers, morphology, cell cycle progression, and apoptosis induction in oesophageal carcinoma cells","volume":"27","author":"Thaver","year":"2009","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/ol.2017.6165","article-title":"Effect of 2-methoxyestradiol on SK-LMS-1 uterine leiomyosarcoma cells","volume":"14","author":"Lee","year":"2017","journal-title":"Oncol Lett"},{"issue":"8","key":"10.1016\/j.xphs.2023.07.018_bib0016","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jsgi.2006.09.003","article-title":"Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids","volume":"13","author":"Salama","year":"2006","journal-title":"J Soc Gynecol Investig"},{"issue":"10","key":"10.1016\/j.xphs.2023.07.018_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007356","article-title":"Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells","volume":"4","author":"Salama","year":"2009","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.xphs.2023.07.018_bib0018","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1158\/1078-0432.CCR-05-0440","article-title":"A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer","volume":"11","author":"Sweeney","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10637-006-9008-5","article-title":"Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer","volume":"25","author":"James","year":"2007","journal-title":"Invest New Drugs"},{"issue":"6","key":"10.1016\/j.xphs.2023.07.018_bib0020","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/mp100190f","article-title":"Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges","volume":"7","author":"Verenich","year":"2010","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2023.07.018_bib0021","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.cad.0000224447.08706.92","article-title":"Plasma protein binding of the investigational anticancer agent 2-methoxyestradiol","volume":"17","author":"Lakhani","year":"2006","journal-title":"Anticancer Drugs"},{"issue":"6","key":"10.1016\/j.xphs.2023.07.018_bib0022","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/17425247.5.6.629","article-title":"Biodegradable polymeric nanocarriers for pulmonary drug delivery","volume":"5","author":"Rytting","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2023.07.018_bib0023","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-60761-609-2_11","article-title":"Polymeric nanoparticles for drug delivery","volume":"624","author":"Chan","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2023.07.018_bib0024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(03)00224-2","article-title":"Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles","volume":"259","author":"Avgoustakis","year":"2003","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2023.07.018_bib0025","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4155\/tde.15.79","article-title":"Transport of digoxin-loaded polymeric nanoparticles across BeWo cells, an in vitro model of human placental trophoblast","volume":"6","author":"Albekairi","year":"2015","journal-title":"Ther Deliv"},{"key":"10.1016\/j.xphs.2023.07.018_bib0026","doi-asserted-by":"crossref","unstructured":"I. Kalashnikova, N. Albekairi, S. Al-Enazy, and E. Rytting, Characterization of Drug-Loaded Nanoparticles. In Nano Based Drug Delivery, Naik J, ed., IAPC Publishing, Zagreb, 2015., Naik J., ed., Zagreb: IAPC Publishing, 2015.","DOI":"10.5599\/obp.8.4"},{"issue":"9","key":"10.1016\/j.xphs.2023.07.018_bib0027","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.bpj.2012.03.013","article-title":"Tracking UNC-45 chaperone-myosin interaction with a titin mechanical reporter","volume":"109","author":"Kaiser","year":"2012","journal-title":"Biophys J"},{"issue":"6681","key":"10.1016\/j.xphs.2023.07.018_bib0028","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/30270","article-title":"The molecular elasticity of the extracellular matrix protein tenascin","volume":"393","author":"Oberhauser","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.xphs.2023.07.018_bib0029","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-2836(02)00306-6","article-title":"The mechanical hierarchies of fibronectin observed with single-molecule AFM","volume":"319","author":"Oberhauser","year":"2002","journal-title":"J Mol Biol"},{"issue":"10","key":"10.1016\/j.xphs.2023.07.018_bib0030","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1529\/biophysj.106.088989","article-title":"The mechanical properties of E. coli type 1 pili measured by atomic force microscopy techniques","volume":"91","author":"Miller","year":"2006","journal-title":"Biophys J"},{"issue":"7","key":"10.1016\/j.xphs.2023.07.018_bib0031","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1073\/pnas.96.7.3694","article-title":"Mechanical and chemical unfolding of a single protein: a comparison","volume":"96","author":"Carrion-Vazquez","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.xphs.2023.07.018_bib0032","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","article-title":"Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics","volume":"82","author":"Carney","year":"2002","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.xphs.2023.07.018_bib0033","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1080\/01443615.2022.2033964","article-title":"Simvastatin-loaded liposome nanoparticles treatment for uterine leiomyoma in a patient-derived xenograft mouse model: a pilot study","volume":"42","author":"El Sabeh","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.xphs.2023.07.018_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105856","article-title":"Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation","volume":"172","author":"Afrin","year":"2021","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.xphs.2023.07.018_bib0035","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.fertnstert.2009.08.065","article-title":"Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells","volume":"94","author":"Zhang","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.xphs.2023.07.018_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/JPRI\/2017\/34606","article-title":"Cytotoxicity of endocytosis and efflux inhibitors in the BeWo Cell Line","volume":"17","author":"Shah","year":"2017","journal-title":"J Pharm Res Int"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0037","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s43032-020-00248-w","article-title":"Liposomal 2-methoxyestradiol nanoparticles for treatment of uterine leiomyoma in a patient-derived xenograft mouse model","volume":"28","author":"Borahay","year":"2021","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.07.018_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-00009577-200503000-00019","article-title":"Antiproliferative activity and toxicity of 2-methoxyestradiol in cervical cancer xenograft mice","volume":"15","author":"Li","year":"2005","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0039","doi-asserted-by":"crossref","DOI":"10.1007\/s10637-006-9008-5","article-title":"Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer","volume":"25","author":"James","year":"2007","journal-title":"Invest New Drugs"},{"issue":"4","key":"10.1016\/j.xphs.2023.07.018_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/08982104.2018.1556293","article-title":"Synthesis and in vitro characterization of oxytocin receptor targeted PEGylated immunoliposomes for drug delivery to the uterus","volume":"29","author":"Hua","year":"2019","journal-title":"J Liposome Res"},{"issue":"2","key":"10.1016\/j.xphs.2023.07.018_bib0041","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4155\/tde.10.13","article-title":"Nanoparticle-assisted combination therapies for effective cancer treatment","volume":"1","author":"Hu","year":"2010","journal-title":"Ther Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2023.07.018_bib0042","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/pharmaceutics13020191","article-title":"Polycaprolactone nanoparticles as promising candidates for nanocarriers in novel nanomedicines","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.xphs.2023.07.018_bib0043","doi-asserted-by":"crossref","DOI":"10.1021\/mp300559v","article-title":"Quantitative detection of PLGA nanoparticle degradation in tissues following intravenous administration","volume":"10","author":"Mohammad","year":"2013","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0044","doi-asserted-by":"crossref","DOI":"10.1007\/s43032-020-00248-w","article-title":"Liposomal 2-methoxyestradiol nanoparticles for treatment of uterine leiomyoma in a patient-derived xenograft mouse model","volume":"28","author":"Borahay","year":"2021","journal-title":"Reprod Sci"},{"issue":"6","key":"10.1016\/j.xphs.2023.07.018_bib0045","doi-asserted-by":"crossref","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.xphs.2023.07.018_bib0046","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.taap.2010.09.002","article-title":"In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles","volume":"249","author":"Semete","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2023.07.018_bib0047","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1208\/s12248-021-00611-y","article-title":"FDA's poly (lactic-co-glycolic acid) research program and regulatory outcomes","volume":"23","author":"Wang","year":"2021","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2023.07.018_bib0048","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1038\/s41598-023-33463-x","article-title":"One to one comparison of cell-free synthesized erythropoietin conjugates modified with linear polyglycerol and polyethylene glycol","volume":"13","author":"Pouyan","year":"2023","journal-title":"Sci Rep"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923002940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923002940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:44:00Z","timestamp":1758361440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923002940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0022354923002940"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.07.018","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}